Kytril Oral Tablet 1Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Kytril: Oral tablet (1mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_6821.JPG
Kytril 1mg Tab
Genentech Inc
Pill Identification: K1 
Drug Image file DrugItem_14353.JPG
Granisetron 1mg Tab
Northstar Rx LLC
Pill Identification: G1 
Drug Image file DrugItem_14352.JPG
Granisetron 1mg Tab
Northstar Rx LLC
Pill Identification: G1 
Drug Image file DrugItem_21341.JPG
Granisetron 1mg Tab
Karalex Pharma, LLC
Pill Identification: G1 
Drug Image file DrugItem_21343.JPG
Granisetron 1mg Tab
Karalex Pharma, LLC
Pill Identification: G1 

What is this Medicine?

GRANISETRON (gra NI se tron) is used to prevent nausea and vomiting caused by chemotherapy or radiation therapy.

Similar Generic Drugs : Granisetron: Oral tablet (1mg)
In-Depth Information

Kytril 1mg Tablet

NDC: 000040241
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Radiation-induced Nausea/vomiting Prophylaxis, Chemotherapy-induced Nausea/vomiting, Chemotherapy-induced Nausea/vomiting Prophylaxis

Storage Information
Protect from light
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Kytril 1mg Tablet
Drug Image file DrugItem_6821.JPG
Genentech Inc
Pill Identification: K1 
Shape: triangular (3-sided)
Color: white

Reported Side Effects for Kytril 1mg Tablet

Inability To Sleep Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Distressed Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Nervousness Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Headache Incidence:
0.7-21.0%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
1.0%*
Severity: MILD
Onset: EARLY
Drowsiness Incidence:
1.0-4.0%*
Severity: MILD
Onset: EARLY
High Blood Pressure Incidence:
1.0-2.0%*
Severity: MODERATE
Onset: EARLY
Low Platelet Count Incidence:
2.0%*
Severity: MODERATE
Onset: DELAYED
Metallic Taste Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Elevated Hepatic Enzymes Incidence:
2.8-6.0%*
Severity: MODERATE
Onset: DELAYED
Constipation Incidence:
3.0-18.0%*
Severity: MODERATE
Onset: DELAYED
Fever Incidence:
3.0-5.0%*
Severity: MILD
Onset: EARLY
Hair Loss Incidence:
3.0%*
Severity: MILD
Onset: DELAYED
Stomach Pain Incidence:
4.0-6.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
4.0-6.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
4.0-9.0%*
Severity: MILD
Onset: EARLY
Anemia Incidence:
4.0%*
Severity: MODERATE
Onset: DELAYED
Lightheadedness Incidence:
5.0%*
Severity: MILD
Onset: EARLY
Weakness Incidence:
5.0-18.0%*
Severity: MILD
Onset: DELAYED
Decreased Appetite Incidence:
6.0%*
Severity: MILD
Onset: DELAYED
Low White Blood Cell Counts Incidence:
9.0%*
Severity: MODERATE
Onset: DELAYED
Vomiting Incidence:
12.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
20.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Kytril

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5